{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:05:15Z","timestamp":1784023515274,"version":"3.55.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1093\/ckj\/sfag198","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:52:08Z","timestamp":1781092328000},"source":"Crossref","is-referenced-by-count":0,"title":["A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5686-2116","authenticated-orcid":false,"given":"Naga Sumanth Reddy","family":"Gopireddy","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City , IA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Yale School of Medicine , NewHaven, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J H","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City , IA ,","place":["USA"]},{"name":"Iowa Institute of Human Genetics, University of Iowa , Iowa City, IA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M","family":"Nester","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City , IA ,","place":["USA"]},{"name":"Division of Pediatric Nephrology, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City , IA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-9685","authenticated-orcid":false,"given":"Christie P","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City , IA ,","place":["USA"]},{"name":"Iowa Institute of Human Genetics, University of Iowa , Iowa City, IA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"2026071405112318700_bib1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"2026071405112318700_bib2","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.trre.2024.100857","article-title":"Recurrent complement-mediated hemolytic uremic syndrome after kidney transplantation","volume":"38","author":"Obata","year":"2024","journal-title":"Transplant Rev"},{"key":"2026071405112318700_bib3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ekir.2023.01.016","article-title":"Eculizumab rescue therapy in patients with recurrent atypical hemolytic uremic syndrome after kidney transplantation","volume":"8","author":"Duineveld","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026071405112318700_bib4","doi-asserted-by":"publisher","first-page":"e70278","DOI":"10.1111\/ctr.70278","article-title":"Effectiveness and safety of switching to ravulizumab from eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome: a global aHUS registry analysis","volume":"39","author":"Gaeckler","year":"2025","journal-title":"Clin Transplant"},{"key":"2026071405112318700_bib5","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag198\/68507002\/sfag198.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag198\/68507002\/sfag198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag198\/68507002\/sfag198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:11:30Z","timestamp":1784020290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag198\/8705445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag198","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,10]]},"article-number":"sfag198"}}